Kolexia
Hezard Nathalie Biologie médicale
Hezard Nathalie
Biologie médicale
Hôpital La Timone
Marseille, France
56 Activités
1 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thrombose Hémophilie A COVID-19 Thrombopénie Déficit en facteur V Maladies de von Willebrand Hémorragie Thrombose veineuse Thrombocytémie essentielle

Collaborateurs

Voir plus
Nguyen Philippe
Nguyen Philippe
Hôpital Robert-Debré Reims, Reims, France
Ternisien Catherine
Ternisien Catherine
Hôpital Hôtel-Dieu Nantes, Nantes, France
Morange Pierre-Emmanuel
Morange Pierre-Emmanuel
Hôpital La Timone, Marseille, France
Alessi Marie Christine
Alessi Marie Christine
Hôpital La Timone, Marseille, France

Industries

Voir plus
LFB
5 collaboration(s)
Dernière en 2023
Bayer
2 collaboration(s)
Dernière en 2023
Sobi
2 collaboration(s)
Dernière en 2023
Siemens Healthcare
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Surgery in rare bleeding disorders: the prospective MARACHI study.
Research and practice in thrombosis and haemostasis   06 septembre 2023
Early changes in bleeding perception and quality of life in children and adolescents receiving emicizumab prophylaxis for severe haemophilia A without inhibitor.
Haemophilia : the official journal of the World Federation of Hemophilia   16 décembre 2022
Comparative profiles of routine and specialized biomarkers of coagulopathy and endotheliopathy in moderate and severe COVID-19 disease: A prospective observational study
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Quantification of platelet Filamin A by flow cytometry and immunofluorescence does not support the pathogenicity of FLNA missense compared to nonsense variants
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Comparative profiles of routine and specialized biomarkers of coagulopathy and endotheliopathy in moderate and severe COVID-19 disease: a prospective observational study
Proceedings of Reanimation 2022, the French Intensive Care Society International Congress   22 juin 2022
Early measurement of alveolar epithelial and endothelial biomarkers in serum predicts the need for mechanical ventilation in patients with COVID-19 pneumonia
Proceedings of Reanimation 2022, the French Intensive Care Society International Congress   22 juin 2022
Syndrome MYH9
HAS Publications   17 novembre 2021
Evolution of Emicizumab Plasma Concentrations and aPTT rratio in 183 Treated Patients with Severe Haemophilia A. A Real Life and Multi-centre Analysis
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besançon).
Journal of thrombosis and haemostasis : JTH   08 avril 2021
Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals).
European journal of haematology   16 septembre 2020